This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Personal history of allergy to analgesic agent
Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
207 |
4. Check minimum number of eventsNone |
207 |
5. Include endpointsNone |
207 |
6. Filter based on genotype QC (FinnGen only) |
207 |
Control definitions (FinnGen only)
- Control exclude
- CD2_BENIGN_FEMALE_GEN_OTH
Extra metadata
- Level in the ICD hierarchy
- 4
- Special
- ASAINTOL
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z88
Similar endpoints
↥List of similar endpoints to
Personal history of allergy to analgesic agent
based on the number of shared cases.
Similar with more cases:
- Personal history of allergy to drugs, medicaments and biological substances
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 207 | 140 | 67 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.03 |
| Median age at first event (years) | 52.32 | 50.91 | 55.25 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 181
- Matched controls
- 1808
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
+∞
261.9
181
*
J33.0
ICD-10 Finland
Polyp of nasal cavity
124.8
105.6
108
21
J32.4
ICD-10 Finland
Chronic pansinusitis
179.4
101.3
99
12
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
109.0
97.7
102
21
J33.8
ICD-10 Finland
Other polyp of sinus
127.1
85.1
87
13
UDH02
NOMESCO Finland
Rhinopharyngoscopy
44.7
82.8
105
54
J45.1
ICD-10 Finland
Nonallergic asthma
47.1
82.0
102
48
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
43.4
80.1
102
52
R03DC03
ATC
montelukast; oral
25.2
77.4
133
179
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
24.6
76.5
133
183
DHB20
NOMESCO Finland
Polypectomy of internal nose
140.5
74.0
75
9
J45.0
ICD-10 Finland
Predominantly allergic asthma
27.4
68.9
102
81
R01AD08
ATC
fluticasone; nasal
18.6
63.6
149
361
J45.9
ICD-10 Finland
Asthma, unspecified
16.2
58.9
116
179
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
47.8
58.6
71
24
XQ800
NOMESCO Finland
Prick test
19.2
51.0
84
78
TDM10
NOMESCO Finland
Puncture of maxillary antrum
26.4
51.0
73
45
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
18.5
49.8
83
79
C01CA24
ATC
epinephrine; parenteral
19.7
47.4
76
64
DPA30
NOMESCO Finland
Sphenotomy
288.4
45.1
44
*
H02AB06
ATC
prednisolone; systemic
12.8
44.9
156
592
R01AD05
ATC
budesonide; nasal
17.5
44.6
75
70
R03BB04
ATC
tiotropium bromide; inhalant
21.4
41.4
63
44
R03AC02
ATC
salbutamol; inhalant
12.9
38.7
163
746
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
15.9
37.2
64
60
R03AK06
ATC
salmeterol and fluticasone; inhalant
10.0
35.6
82
138
ZXA10
NOMESCO Finland
Bilateral
9.1
35.5
89
173
R03BA02
ATC
budesonide; inhalant
8.6
33.6
88
180
H02AB04
ATC
methylprednisolone; systemic
9.7
33.6
78
131
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
200.3
32.9
33
*
R03BA05
ATC
fluticasone; inhalant
7.6
30.1
85
189
J33.9
ICD-10 Finland
Nasal polyp, unspecified
77.1
29.0
32
5
H02AB07
ATC
prednisone; oral
7.9
28.9
77
155
R03DA04
ATC
theophylline; systemic, rectal
28.6
26.0
35
15
J45
ICD-10 Finland
Asthma
9.2
25.6
58
88
ZXE00
NOMESCO Finland
One hour or less
5.4
24.9
121
493
R03AK07
ATC
formoterol and budesonide; inhalant
5.8
23.4
82
227
R03AK08
ATC
formoterol and beclometasone; inhalant
17.0
22.5
36
26
R01AD09
ATC
mometasone; nasal
5.1
22.2
136
671
M01AE01
ATC
ibuprofen; systemic, rectal
0.2
21.9
88
1496
ZXE10
NOMESCO Finland
More than one and less than three hours
4.8
21.9
108
424
ZXC95
NOMESCO Finland
Use of surgical navigator
34.9
21.3
27
9
ZXD10
NOMESCO Finland
Scheduled procedure
4.7
21.2
111
458
R01AD12
ATC
fluticasone furoate; nasal
4.7
21.0
103
398
R03AC12
ATC
salmeterol; inhalant
20.5
20.9
31
18
R03AC13
ATC
formoterol; inhalant
12.6
19.8
36
35
J46
ICD-10 Finland
Status asthmaticus
18.7
19.6
30
19
Z2221
NOMESCO Finland
Medical doctor
4.5
19.4
92
336
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
17.9
18.7
29
19
WX408
NOMESCO Finland
General anesthesy, balanced
4.6
18.7
84
289
R06AX27
ATC
desloratadine; oral
4.3
18.6
96
373
J01AA02
ATC
doxycycline; systemic
7.9
18.3
169
1157
DHA10
NOMESCO Finland
Biopsy of cavity of nose
198.6
17.8
18
*
R06AE07
ATC
cetirizine; oral
4.0
17.6
120
592
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
4.3
17.3
81
285
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
11.5
17.0
32
33
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
99.4
16.9
18
*
WX002
NOMESCO Finland
Sedation and analgesia
4.8
16.5
64
185
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
52.7
16.4
19
*
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
11.8
16.2
30
30
DHB50
NOMESCO Finland
Turbinoplasty
15.8
16.1
26
19
D72.1
ICD-10 Finland
Eosinophilia
+∞
15.9
15
*
R01AD01
ATC
beclometasone; nasal
4.9
15.8
58
158
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
10.5
15.7
31
35
R03AC03
ATC
terbutaline; inhalant
5.0
15.4
56
150
R06AE09
ATC
levocetirizine; oral
4.6
15.4
62
185
4222
FHL
Endonasal etmoidectomy
49.7
15.4
18
*
J33
ICD-10 Finland
Nasal polyp
87.4
14.8
16
*
R06AX13
ATC
loratadine; oral
4.5
14.3
58
173
R03BA01
ATC
beclometasone; inhalant
5.0
14.3
50
128
Z3231
NOMESCO Finland
Registered nurse
3.9
14.2
73
269
J45.8
ICD-10 Finland
Mixed asthma
14.4
13.9
23
18
XG474
NOMESCO Finland
Exhalation nntrogen oxide
15.5
13.7
22
16
4711A
ICD-9 Finland
Nasal polyps, Polypoid sinus degeneration
150.8
13.6
14
*
J32.8
ICD-10 Finland
Other chronic sinusitis
150.8
13.6
14
*
R03BA08
ATC
ciclesonide; inhalant
6.1
13.5
38
75
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.4
13.1
126
733
ZX112
NOMESCO Finland
Subcutaneous
26.6
12.7
17
7
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.5
12.0
69
269
Z51.6
ICD-10 Finland
Desensitization to allergens
18.0
11.9
18
11
ZXD20
NOMESCO Finland
Day surgery
4.3
11.8
48
141
R03DC01
ATC
zafirlukast; oral
27.0
11.3
15
6
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
6.7
11.0
28
48
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.0
10.6
26
42
J33.1
ICD-10 Finland
Polypoid sinus degeneration
+∞
10.5
10
*
T78.4
ICD-10 Finland
Allergy, unspecified
6.9
10.5
26
43
J01FA09
ATC
clarithromycin; systemic
2.9
10.2
86
431
J01FA10
ATC
azithromycin; systemic
3.0
10.1
136
908
WX402
NOMESCO Finland
General anaesthesia
3.5
10.0
53
193
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
27.8
10.0
13
5
R03AK11
ATC
formoterol and fluticasone; inhalant
12.4
9.8
17
15
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.9
9.6
42
130
R03BB01
ATC
ipratropium bromide; inhalant
18.8
9.6
14
8
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
13.4
9.6
16
13
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
9.4
87
456
J01FA06
ATC
roxithromycin; oral
2.7
9.1
94
523
R06AX22
ATC
ebastine; oral
3.1
9.1
56
226
R01BA52
ATC
pseudoephedrine, combinations; oral
2.8
9.0
78
389
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.6
8.8
20
29
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
17.4
8.7
13
8
N02AX02
ATC
tramadol; systemic, rectal
2.6
8.6
88
481
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
8.6
8.6
18
23
R96
ICPC
Asthma
4.7
8.6
29
70
XQ820
NOMESCO Finland
Exposure to medicinal substance
29.1
8.6
11
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
10.8
8.2
15
15
Z01.7
ICD-10 Finland
Laboratory examination
3.9
8.0
34
102
DJD20
NOMESCO Finland
Plastic repair of septum of nose
7.3
7.8
18
27
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
7.7
98
592
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.8
7.6
33
101
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
7.5
87
498
297
Kela drug reimbursment
NA
+∞
7.3
7
*
3028
Kela drug reimbursment
Mepolizumab
+∞
7.3
7
*
R03DX09
ATC
mepolizumab; parenteral
+∞
7.3
7
*
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
16.6
7.3
11
7
J01DA06
ATC
[U] cefuroxime; systemic
3.1
7.3
42
160
N02BE01
ATC
paracetamol; systemic, rectal
3.2
7.3
160
1277
J34.2
ICD-10 Finland
Deviated nasal septum
5.1
7.2
22
48
R4110
NOMESCO Finland
Physiotherapy
2.6
7.1
63
311
A02BC05
ATC
esomeprazole; systemic
2.3
6.8
83
481
DFF00
NOMESCO Finland
Pure tone audiometry
4.8
6.8
22
51
J01CA04
ATC
amoxicillin; systemic
3.2
6.8
162
1319
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
12.9
6.7
11
9
DPA20
NOMESCO Finland
Trephine of frontal sinus
72.3
6.5
7
*
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
72.3
6.5
7
*
Z3226
NOMESCO Finland
Physiotherapist
2.8
6.4
45
191
UDM02
NOMESCO Finland
Sinoscopy
7.5
6.4
14
20
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.8
6.3
17
32
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
18.8
6.3
9
5
4239
FHL
Other measure in this category
+∞
6.3
6
*
4224
FHL
Endonasal anthrostomy
13.1
6.2
10
8
J30.3
ICD-10 Finland
Other allergic rhinitis
5.9
6.2
16
29
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
6.1
49
227
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3010726) Horse dander IgE Ab [Units/volume] in Serum
63
23
38.94
96.36
1.5
1.0
u/ml
0.5
3.9
—
40
5
(3003888) Timothy IgE Ab [Units/volume] in Serum
67
31
31.48
94.34
1.5
1.1
u/ml
1.7
4.7
0.72
61
17
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
70
37
28.07
93.47
1.5
1.2
u/ml
0.5
0.8
0.45
61
16
(3008401) Mugwort IgE Ab [Units/volume] in Serum
64
28
32.64
91.89
1.5
1.1
u/ml
0.3
0.9
0.48
58
14
(4010399)
89
118
12.48
69.14
1.8
1.4
—
—
—
0
0
(3000492) Spirometry study
97
168
9.98
60.15
1.8
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
168
551
11.88
57.02
4.5
5.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
35
12
34.90
53.45
1.3
1.1
u/ml
1.3
0.1
—
18
6
(3022096) Basophils/100 leukocytes in Blood
185
774
14.08
46.09
6.0
6.1
%
0.8
0.7
2.57
180
722
(3006504) Eosinophils/100 leukocytes in Blood
185
803
13.27
43.36
6.0
6.0
%
5.2
2.7
14.09
180
749
(3019069) Monocytes/100 leukocytes in Blood
185
810
13.08
42.72
6.1
6.3
%
7.9
8.2
1.33
180
764
(3001604) Monocytes [#/volume] in Blood
189
862
14.71
41.35
6.1
5.9
e9/l
0.6
0.5
0.98
158
765
(3006315) Basophils [#/volume] in Blood
189
864
14.66
41.18
6.0
6.0
e9/l
0.1
0.0
5.79
158
766
(3018010) Neutrophils/100 leukocytes in Blood
184
832
11.90
40.01
5.9
5.7
%
54.1
56.9
3.00
179
786
(3002030) Lymphocytes/100 leukocytes in Blood
185
843
12.24
39.85
6.1
5.9
%
28.4
29.1
0.55
180
795
(3013115) Eosinophils [#/volume] in Blood
190
892
14.76
39.66
6.2
6.6
e9/l
0.4
0.2
14.72
162
807
(3019198) Lymphocytes [#/volume] in Blood
189
897
13.73
38.50
6.1
6.0
e9/l
2.1
2.0
0.52
161
813
(3021589) Normoblasts [#/volume] in Blood
175
771
9.21
38.43
7.7
7.8
e9/l
0.0
0.0
0.62
128
632
(3007853) Bacteria identified in Skin by Aerobe culture
83
189
6.66
37.83
2.6
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
84
208
6.11
34.68
2.5
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
190
1008
11.78
31.23
6.8
9.6
e9/l
4.0
4.0
0.12
159
888
(40758558) Short blood count panel - Blood
113
411
4.85
28.55
4.6
7.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
62
189
4.26
18.66
2.4
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
138
726
3.70
18.08
2.5
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
42
108
4.62
15.58
1.2
1.2
—
—
—
0
0
(4062490)
18
19
10.28
15.44
1.3
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
16
10.75
14.20
1.6
2.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
28
62
5.07
12.31
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
31
86
4.06
10.27
1.2
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
20
40
5.43
9.79
1.5
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
33
5.88
9.63
2.5
5.5
%
58.6
57.9
0.08
18
33
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
33
5.88
9.63
2.5
4.5
e9/l
4.8
4.8
0.01
18
33
(3009542) Hematocrit [Volume Fraction] of Blood
200
1691
6.40
9.40
15.8
12.0
%
41.6
40.5
3.35
176
1368
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
11
13
8.88
8.54
1.2
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
13
9
15.30
8.32
1.3
3.4
ug/l
40.3
18.0
—
13
9
(3007164) IgA [Mass/volume] in Serum or Plasma
75
389
2.46
8.31
1.5
1.3
g/l
2.2
2.2
0.26
46
245
(3044889) 12 lead EKG panel
155
1109
2.58
8.20
3.4
3.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
13
8.03
7.18
5.4
2.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
30
4.93
6.31
1.4
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
192
1637
3.39
5.43
11.5
9.9
ml/min/173m2
91.1
89.1
0.85
168
1325
(3030467) Casts [#/volume] in Urine by Automated count
70
415
2.04
5.22
3.1
2.6
e6/l
0.2
0.4
0.80
43
309
(36304419) Bacteria [Presence] in Urine
70
419
2.01
5.06
3.1
2.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
35
158
2.46
5.04
2.0
2.3
u/l
25.3
28.6
0.95
26
131
(44813793)
9
10
9.34
4.83
1.2
1.2
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
11
25
4.59
4.62
7.9
2.8
kpa
8.8
9.1
0.23
11
25
(3012501) Base excess in Blood by calculation
11
25
4.59
4.62
7.9
2.8
mmol/l
2.4
3.1
0.34
11
19
(3013290) Carbon dioxide [Partial pressure] in Blood
11
25
4.59
4.62
7.9
2.8
kpa
5.3
5.1
0.21
11
25
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
29
128
2.47
4.37
3.8
3.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
71
446
1.90
4.36
1.7
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
72
461
1.86
4.14
3.1
2.6
e6/l
17.3
44.2
1.09
46
354
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
20
75
2.84
4.13
6.2
4.6
mmol/l
25.8
25.0
0.43
20
75
(3018095) Leukocytes [#/volume] in Urine
83
559
1.81
4.04
3.6
3.2
e6/l
13.5
37.8
1.23
49
381
(40760892) CBC W Ordered Manual Differential panel - Blood
69
444
1.83
3.87
5.2
5.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
18
67
2.85
3.77
2.5
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
66
423
1.82
3.73
3.0
3.8
ph
7.4
7.4
0.64
16
67
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
19
75
2.69
3.58
2.1
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
26
3.99
3.56
3.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
5
189
0.25
3.46
3.4
4.2
%
38.4
31.7
—
5
121
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
27
3.84
3.39
1.5
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
27
3.84
3.39
1.5
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
58
367
1.81
3.38
1.7
1.7
mg/l
2.1
0.9
0.37
44
285
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
41
235
1.93
3.24
2.0
2.5
e6/l
1.4
2.8
0.86
13
116
(3000963) Hemoglobin [Mass/volume] in Blood
207
1988
+∞
3.22
19.9
17.1
g/l
137.7
136.6
0.60
207
1965
(3035941) MCH [Entitic mass]
207
1986
+∞
3.19
19.7
16.9
pg
30.1
30.2
0.59
207
1964
(3024731) MCV [Entitic volume]
207
1986
+∞
3.19
19.7
17.0
fl
90.6
90.5
0.13
207
1965
(3023368) Bacteria identified in Blood by Culture
55
349
1.78
3.16
4.0
4.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
21
4.43
3.03
7.2
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
194
1761
2.62
3.01
13.2
11.0
mg/l
23.1
21.1
0.33
166
1325
(3026493) Urate [Moles/volume] in Serum or Plasma
61
407
1.71
2.92
2.0
2.5
umol/l
310.0
5169.3
1.46
51
361
(3000850) Epithelial cells [#/volume] in Urine
49
310
1.76
2.82
3.1
2.2
e6/l
5.7
5.3
0.09
40
275
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
6
8.50
2.76
1.4
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
42
257
1.80
2.70
2.0
2.4
e6/l
0.5
0.8
0.34
13
135
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
107
2.18
2.69
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
50
2.71
2.58
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
50
2.71
2.58
1.0
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
73
525
1.60
2.57
3.2
2.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
63
437
1.63
2.57
1.3
1.3
u/ml
0.7
1.3
1.09
12
132
(42529406) Shigella sp [Presence] in Stool by Culture
13
51
2.65
2.49
1.0
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
34
201
1.83
2.44
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
29
163
1.91
2.42
1.1
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
12
5.11
2.42
1.0
2.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
22
3.74
2.39
1.1
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
27
149
1.93
2.38
1.5
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
25
135
1.97
2.34
4.9
3.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
25
136
1.95
2.30
1.2
1.5
—
—
—
0
0
(4034850)
0
59
0.00
2.28
0.0
10.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
29
3.20
2.25
1.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
67
2.34
2.23
1.5
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
15
67
2.34
2.23
1.5
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
154
1.87
2.17
1.5
1.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
14
4.38
2.16
3.5
2.4
%
92.7
90.6
—
6
14
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
37
2.79
2.13
1.2
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
43
284
1.65
2.10
3.4
2.3
mosm/kgh2o
547.6
583.0
0.37
36
244
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
69
2.27
2.10
1.7
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
31
2.99
2.10
1.6
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
157
1377
1.58
2.09
4.1
3.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
39
253
1.67
2.04
2.7
2.4
mmol/l
2.4
2.4
0.26
32
224
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
57
2.37
2.02
1.2
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
181
1652
1.76
1.97
3.4
3.9
mmol/l
5.6
5.8
0.75
166
1538
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
27
3.04
1.95
1.0
1.1
—
—
—
0
0
(3036489) Thrombin time
13
58
2.32
1.95
1.3
1.7
s
22.5
22.1
0.08
13
50
(3021788) Differential panel - Synovial fluid
6
16
3.83
1.95
1.5
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
65
2.24
1.93
1.3
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
148
1292
1.51
1.92
2.4
3.0
u/l
30.2
41.7
4.27
141
1226
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
80
2.08
1.85
1.7
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
60
441
1.51
1.85
2.0
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
38
254
1.61
1.77
2.9
3.3
ng/l
18.0
274.1
1.11
23
170
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
103
848
1.43
1.75
3.6
5.9
umol/l
9.5
10.3
0.80
95
806
(3037522) Nuclear Ab [Titer] in Serum
37
250
1.58
1.65
1.2
1.4
titre
301.8
534.0
0.88
11
57
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
31
202
1.63
1.60
1.6
2.5
umol/l
4.1
6.6
1.21
24
167
(3023323) Follitropin [Units/volume] in Serum or Plasma
20
115
1.82
1.59
1.4
1.3
iu/l
18.3
24.2
0.52
15
101
(3022145) Colonoscopy Study observation
28
180
1.64
1.53
1.3
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
33
223
1.57
1.48
1.8
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
66
2.03
1.47
2.5
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
132
1158
1.39
1.44
4.0
3.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
150
1346
1.42
1.42
3.7
4.1
pmol/l
14.2
14.5
1.07
139
1242
(3021601) Nitrite [Presence] in Urine by Test strip
99
832
1.36
1.40
3.8
4.4
estimate
0.0
0.0
0.00
21
161
(3025941) Bacteria identified in Stool by Culture
17
97
1.82
1.40
1.3
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
82
1.89
1.39
1.5
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
82
1.89
1.39
1.5
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
82
1.89
1.39
1.5
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
82
1.89
1.39
1.5
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
30
202
1.57
1.37
1.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
17
2.99
1.36
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
39
0.00
1.35
0.0
3.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
37
263
1.50
1.33
1.6
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
84
693
1.36
1.32
2.1
2.3
nmol/l
73.2
75.7
0.34
73
627
(3015377) Calcium [Moles/volume] in Serum or Plasma
66
525
1.38
1.30
2.9
3.3
mmol/l
2.3
2.4
0.55
57
461
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
48
2.14
1.30
1.6
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
98
830
1.34
1.29
2.7
3.2
estimate
0.0
0.0
0.00
22
155
(3044941) Cell count panel - Synovial fluid
5
18
2.82
1.29
1.6
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
18
2.82
1.29
1.2
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
76
622
1.35
1.25
2.7
4.5
g/l
37.3
36.9
0.31
67
588
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
56
2.02
1.24
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
18
109
1.71
1.23
4.6
6.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
99
844
1.33
1.23
2.7
3.2
estimate
0.0
0.0
0.00
20
157
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
37
2.21
1.23
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
191
1.54
1.22
2.1
1.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
82
684
1.33
1.17
3.8
6.2
mmol/l
1.2
1.2
0.36
64
596
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
152
1.58
1.15
1.6
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
195
1865
1.79
1.14
9.6
10.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
51
2.01
1.13
1.3
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
192
0.55
1.12
6.2
6.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
69
569
1.32
1.05
1.9
1.8
pmol/l
94.1
95.5
0.08
34
285
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
56
450
1.34
1.02
1.5
1.6
mmol/l
1.4
1.4
0.14
47
389
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
47
369
1.35
0.99
1.7
1.4
—
—
—
0
0
(4268621)
5
23
2.20
0.98
2.4
2.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
23
2.20
0.98
1.6
2.1
%
52.8
58.3
—
5
23
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
54
1.90
0.98
1.4
1.4
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
30
0.00
0.98
0.0
1.8
—
7.1
—
0
18
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
93
1.66
0.97
1.7
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
139
1268
1.29
0.95
5.7
7.2
u/l
69.8
74.2
1.09
131
1178
(4094501)
7
37
1.92
0.95
1.0
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
30
220
1.43
0.94
2.1
3.1
mmol/l
0.8
0.8
0.99
30
209
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
27
2.26
0.94
2.0
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
27
2.26
0.94
1.5
2.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
47
374
1.33
0.91
2.3
3.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
29
214
1.41
0.89
2.2
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
30
392
0.73
0.85
5.5
4.0
mg/mmol
3.7
12.7
1.88
17
258
(3048689) Calprotectin [Mass/mass] in Stool
33
251
1.37
0.85
1.6
2.3
ug/g
86.4
111.5
0.17
27
191
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
170
1604
1.33
0.83
4.7
4.7
mu/l
1.7
1.8
1.28
162
1492
(3004588) Protein electrophoresis panel - Serum or Plasma
13
82
1.62
0.80
1.3
2.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
0
24
0.00
0.79
0.0
3.3
—
1.5
—
0
19
(3045424) Erythrocytes [Presence] in Urine
0
26
0.00
0.79
0.0
1.7
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
27
0.00
0.78
0.0
2.7
—
7.2
—
0
27
(4035726)
19
133
1.47
0.77
1.1
1.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
28
0.00
0.76
0.0
2.6
—
1.3
—
0
28
(3012516) Albumin [Mass/volume] in Urine
29
372
0.74
0.74
3.9
3.3
mg/l
23.5
85.0
1.85
17
250
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
110
1.49
0.71
1.1
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
41
1.73
0.70
1.7
2.0
—
—
—
0
0
(4306422)
5
28
1.80
0.66
1.2
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
52
438
1.25
0.66
2.2
2.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
57
486
1.24
0.65
2.7
2.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
52
1.56
0.60
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
92
831
1.19
0.59
3.1
2.8
ug/l
100.4
88.5
0.13
84
777
(3019309) Folate [Moles/volume] in Red Blood Cells
28
222
1.30
0.58
1.8
1.5
nmol/l
1157.2
1213.7
0.09
16
169
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
181
1746
1.29
0.55
3.8
4.3
mmol/l
2.9
2.9
0.04
169
1636
(3017143) Hepatitis C virus Ab [Presence] in Serum
30
242
1.28
0.55
1.3
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
19
143
1.36
0.55
1.6
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
74
1.51
0.54
1.5
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
15
109
1.41
0.52
1.3
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
108
0.64
0.50
1.4
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
58
514
1.18
0.45
1.8
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
72
650
1.17
0.45
2.6
3.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
31
1.63
0.43
2.8
3.4
u/ml
12.2
16.1
—
5
31
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
21
259
0.79
0.42
1.6
1.6
pmol/l
428.7
464.2
0.39
12
231
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
33
1.53
0.41
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
33
1.53
0.41
1.2
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(4146454)
0
15
0.00
0.41
0.0
3.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
15
0.00
0.41
0.0
2.3
—
60.3
—
0
10
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
16
0.00
0.41
0.0
3.1
—
3.9
—
0
16
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
16
0.00
0.41
0.0
3.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
16
0.00
0.41
0.0
3.1
—
106.4
—
0
16
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
31
363
0.83
0.39
4.5
4.3
ug/l
1.5
1.7
0.34
26
320
(3005570) Glucose [Moles/volume] in Urine
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
19
0.00
0.39
0.0
3.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
19
0.00
0.39
0.0
3.4
—
70.5
—
0
19
(3013512) EKG study
35
404
0.84
0.38
2.2
3.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
8
113
0.70
0.38
2.1
3.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
116
1.32
0.38
1.3
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
116
1.32
0.38
1.4
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
15
116
1.32
0.38
1.3
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
26
217
1.23
0.38
3.1
2.6
ug/l
0.4
0.8
2.61
14
129
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
49
548
0.86
0.37
1.7
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
41
1.48
0.36
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
41
1.48
0.36
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
78
0.63
0.36
1.2
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
171
1660
1.17
0.34
3.0
3.6
mmol/l
1.2
1.3
1.21
159
1557
(3052851) Hemolysis interference index of Serum or Plasma
6
46
1.31
0.33
2.2
2.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
12
92
1.32
0.32
1.3
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
47
1.28
0.32
1.7
2.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
36
316
1.17
0.32
1.4
1.3
iu/ml
11.0
24.8
—
9
109
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
76
815
0.89
0.30
3.0
3.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
56
1.26
0.29
1.3
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
42
377
1.14
0.28
1.7
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
57
524
1.12
0.27
6.5
6.4
inr
1.1
1.1
0.61
26
156
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
72
0.69
0.26
1.4
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
96
1.27
0.25
1.3
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
116
1.22
0.22
1.4
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
176
1726
1.13
0.21
3.4
4.0
mmol/l
4.9
4.8
0.39
166
1630
(3022621) pH of Urine by Test strip
8
103
0.77
0.21
1.3
2.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.2
—
5.8
—
0
6
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
11
0.00
0.21
0.0
8.6
—
34.0
—
0
5
(4024509)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
125.1
—
0
11
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(4211845)
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.9
—
16.1
—
0
12
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
1.2
—
0
7
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
0.9
—
0
12
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
13
0.00
0.21
0.0
1.2
—
7.2
—
0
13
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
175
1717
1.12
0.20
3.4
3.9
mmol/l
1.6
1.5
2.23
164
1615
(3032773) Endomysium IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
16
137
1.18
0.19
5.4
6.9
mmol/l
1.5
1.3
0.09
11
108
(3020891) Body temperature
6
53
1.14
0.19
3.3
5.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
76
723
1.08
0.18
2.2
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
70
1.15
0.16
1.3
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
31
284
1.11
0.16
1.7
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
57
540
1.08
0.15
2.8
3.0
ng/l
15.1
43.4
1.77
28
304
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
162
1.12
0.12
1.6
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
229
0.91
0.11
1.7
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
5
46
1.09
0.09
3.8
3.6
u/ml
12.4
233.2
—
5
39
(3034770) Mitochondria Ab [Titer] in Serum
6
55
1.09
0.09
1.2
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
52
500
1.05
0.08
1.9
2.4
u/l
50.2
56.0
1.67
45
465
(3002173) Hemoglobin [Mass/volume] in Arterial blood
10
113
0.88
0.08
7.4
7.4
g/l
123.1
124.0
—
10
108
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
41
392
1.06
0.08
1.7
2.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
166
1.09
0.08
1.3
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
67
1.05
0.08
2.4
2.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
70
0.85
0.08
1.5
2.5
%
0.9
1.5
—
6
70
(3023511) Choriogonadotropin [Units/volume] in Urine
6
75
0.79
0.07
1.0
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
76
1.05
0.07
1.6
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
12
132
0.90
0.07
2.3
2.1
ml/min/173m2
82.2
73.4
—
5
59
(3017732) Neutrophils [#/volume] in Blood
12
132
0.90
0.07
1.2
2.4
e9/l
4.9
4.1
0.47
12
112
(3013826) Glucose [Moles/volume] in Serum or Plasma
90
917
0.97
0.06
3.8
3.9
mmol/l
6.3
6.5
0.55
85
838
(3014576) Chloride [Moles/volume] in Serum or Plasma
17
159
1.08
0.05
4.7
5.6
mmol/l
105.2
104.1
0.37
17
154
(3008898) HLA-B27 [Presence]
10
93
1.08
0.02
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
32
312
1.03
0.02
1.3
1.3
u/ml
5.4
7.0
0.16
14
131
(21494755) Public health laboratory ask at order entry panel
26
266
0.97
0.00
1.4
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
18
184
0.98
0.00
2.7
5.3
mmol/l
1.1
1.0
0.91
18
169
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
28
284
0.98
0.00
3.5
4.1
%
17.3
21.2
—
6
121
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
37
366
1.01
0.00
2.1
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
33
333
0.99
0.00
2.0
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
43
435
0.99
0.00
3.3
3.4
estimate
0.0
0.0
0.50
22
161
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
154
1535
1.01
0.00
4.3
4.8
mmol/mol
38.0
38.5
0.31
144
1453
(3016502) Oxygen saturation in Arterial blood
12
118
1.02
0.00
6.4
7.3
%
92.8
96.4
0.53
12
113
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
73
0.96
0.00
1.1
1.9
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
2057.5
—
0
6
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
9
0.00
0.00
0.0
2.0
—
2.9
—
0
9
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
7
78
0.89
0.00
3.3
5.9
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
1644.8
—
0
8
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
57.3
—
0
5
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.7
—
6.4
—
0
7
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
11.2
—
0
6
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
64
0.94
0.00
3.3
7.8
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012544) pH of Venous blood
13
130
1.00
0.00
2.3
3.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
57.3
—
0
5
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
16.9
—
0
6
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
60
1.00
0.00
1.3
2.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
1.5
—
0
8
(3019977) pH of Arterial blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT – Personal history of allergy to analgesic agent
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).